Loading data
BCAXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Research and development expense | — | 63.6 m USD | 30.6 m USD |
| Operating profit | -155.6 m USD | -82.39 m USD | -39.89 m USD |
| Profit before tax | -137.73 m USD | -67.81 m USD | -51.98 m USD |
| Income tax expense | 217 k USD | 187 k USD | 5 k USD |
| Net income (reported basis) | -137.95 m USD | -68 m USD | -51.99 m USD |
| Basic earnings per share | -2.52 USD/share | -4.05 USD/share | -89.61 USD/share |
| Diluted earnings per share | -2.52 USD/share | -4.05 USD/share | -89.61 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.